These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23928241)

  • 1. Breast magnetic resonance imaging for screening high-risk women.
    Sung JS; Dershaw DD
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):509-17. PubMed ID: 23928241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of women at high risk for breast cancer.
    Narod SA
    Prev Med; 2011 Sep; 53(3):127-30. PubMed ID: 21745498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.
    Kam JK; Naidu P; Rose AK; Mann GB
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):400-6. PubMed ID: 23870334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
    Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
    Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating the genetic make-up of breast cancer: a new fashion?
    Linn SC; Jonkers J
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1065-7. PubMed ID: 17725409
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of breast imaging to screen women at high risk for cancer.
    Sickles EA
    Radiol Clin North Am; 2010 Sep; 48(5):859-78. PubMed ID: 20868890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on screening breast MRI in high-risk women.
    Boetes C
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):149-58, viii-ix. PubMed ID: 21419331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
    Sardanelli F; Podo F; D'Agnolo G; Verdecchia A; Santaquilani M; Musumeci R; Trecate G; Manoukian S; Morassut S; de Giacomi C; Federico M; Cortesi L; Corcione S; Cirillo S; Marra V; ; Cilotti A; Di Maggio C; Fausto A; Preda L; Zuiani C; Contegiacomo A; Orlacchio A; Calabrese M; Bonomo L; Di Cesare E; Tonutti M; Panizza P; Del Maschio A
    Radiology; 2007 Mar; 242(3):698-715. PubMed ID: 17244718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI in high risk women: benefits and problems.
    Cortesi L; Pecchi A; De Matteis E; Filieri E; Battista R; Canossi B; Torricelli P; Federico M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S19-20. PubMed ID: 23083587
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.
    Feig S
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients.
    Mann RM; Bult P; van Laarhoven HW; Span PN; Schlooz M; Veltman J; Hoogerbrugge N
    Eur J Radiol; 2013 Sep; 82(9):1416-22. PubMed ID: 23567481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
    Kuhl CK; Schmutzler RK; Leutner CC; Kempe A; Wardelmann E; Hocke A; Maringa M; Pfeifer U; Krebs D; Schild HH
    Radiology; 2000 Apr; 215(1):267-79. PubMed ID: 10751498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.
    Laitman Y; Feldman DM; Sklair-Levy M; Yosepovich A; Barshack-Nakar I; Brodsky M; Halshtok O; Shalmon A; Gotlieb M; Friedman E
    Clin Breast Cancer; 2018 Aug; 18(4):e695-e698. PubMed ID: 29292184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
    Riedl CC; Luft N; Bernhart C; Weber M; Bernathova M; Tea MK; Rudas M; Singer CF; Helbich TH
    J Clin Oncol; 2015 Apr; 33(10):1128-35. PubMed ID: 25713430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of nonmasslike enhancement at screening breast MR imaging of high-risk premenopausal women.
    Giess CS; Raza S; Birdwell RL
    Radiographics; 2013; 33(5):1343-60. PubMed ID: 24025928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.
    Phi XA; Houssami N; Obdeijn IM; Warner E; Sardanelli F; Leach MO; Riedl CC; Trop I; Tilanus-Linthorst MM; Mandel R; Santoro F; Kwan-Lim G; Helbich TH; de Koning HJ; Van den Heuvel ER; de Bock GH
    J Clin Oncol; 2015 Feb; 33(4):349-56. PubMed ID: 25534390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honing the health message on BRCA mutations.
    Schmidt C
    J Natl Cancer Inst; 2013 Dec; 105(24):1843-4. PubMed ID: 24316597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.